Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

Presentations showcase the power of omnimodal profiling to identify predictive immune signatures, comprehensively profile the tumor microenvironment and reveal novel therapeutic targets for optimized ...

Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

This article is presented by EFPIA with the support of AbbVie I made a trip back to Europe recently, where I spent the vast ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date ...

A new report by Treatment Action Group (TAG) warns that a key ingredient in several vaccines of global health importance may face critical supply bottlenecks in the coming years unless governments, ...

Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date wo ...

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care chemotherapy and a manageable safety profile in the first ...

A research team at Duke University has developed a new AI framework that can uncover simple, understandable rules that govern ...